VAERS reports by lot

GSK Flu lot NA23N: VAERS reports

20 VAERS reports list lot NA23N as a GSK Flu vaccine, received between 2020-10-11 and 2021-04-16. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
20
Reports
5%
Marked serious
0
With a death outcome
7
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)1920%
Neurological1819%
Injection-site / Local reaction1314%
Cardiac / Cardiovascular1112%
Thrombotic / Hematological88%
Musculoskeletal77%
Gastrointestinal66%
Allergic / Anaphylactic44%
Respiratory44%
Dermatological (non-injection-site)44%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Iowa4
Nebraska2
Tennessee2
Minnesota2
New York1
Illinois1
California1
South Dakota1
Kansas1
North Carolina1
Alaska1
Missouri1

Reports by month received

2020-109
2020-116
2020-121
2021-011
2021-021
2021-031
2021-041

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.